JAHA:西藏人群代谢危险因素与左室舒张功能的相关性研究

2019-03-15 不详 MedSci原创

在高海拔和低氧环境下生活的人中,关于代谢危险因素聚类的左心室舒张功能障碍(LVDD)风险的数据尚缺乏。本研究的目的旨在中国西藏人群中探究代谢危险因素与LVDD的相关性。本研究纳入了1963名西藏人群,平均年龄51.51岁,男性占41.11%。其中LVDD的发病率为34.39%,1个危险因素、2个危险因素和3-5个危险因素的LVDD的风险比分别为1.45 (0.96–2.17), 2.68 (1.8

在高海拔和低氧环境下生活的人中,关于代谢危险因素聚类的左心室舒张功能障碍(LVDD)风险的数据尚缺乏。本研究的目的旨在中国西藏人群中探究代谢危险因素与LVDD的相关性。

本研究纳入了1963名西藏人群,平均年龄51.51岁,男性占41.11%。其中LVDD的发病率为34.39%,1个危险因素、2个危险因素和3-5个危险因素的LVDD的风险比分别为1.45 (0.96–2.17), 2.68 (1.8–3.98)和2.9 (1.9–4.43)。代谢危险因素与LVDD的相关性在中年人群中比老年人群中更显着(p=0.0170)。高海拔是LVDD的危险因素之一,然而,居住处的海拔对代谢危险因素和LVDD的相关性无明显影响(p=0.1022)。另外,腹型肥胖、高血压和血糖增高是LVDD的危险因素。

研究结果显示,在高海拔人群中,代谢危险因素的个数与左室舒张功能障碍明显相关。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2026161, encodeId=973d202616111, content=<a href='/topic/show?id=c2968658593' target=_blank style='color:#2F92EE;'>#舒张功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86585, encryptionId=c2968658593, topicName=舒张功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Wed Apr 10 08:47:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837659, encodeId=5862183e65975, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 31 17:47:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268093, encodeId=77b012680933a, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Mar 17 11:47:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362708, encodeId=541e362e08f1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Mar 15 21:48:14 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
    2019-04-10 yahu
  2. [GetPortalCommentsPageByObjectIdResponse(id=2026161, encodeId=973d202616111, content=<a href='/topic/show?id=c2968658593' target=_blank style='color:#2F92EE;'>#舒张功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86585, encryptionId=c2968658593, topicName=舒张功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Wed Apr 10 08:47:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837659, encodeId=5862183e65975, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 31 17:47:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268093, encodeId=77b012680933a, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Mar 17 11:47:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362708, encodeId=541e362e08f1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Mar 15 21:48:14 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2026161, encodeId=973d202616111, content=<a href='/topic/show?id=c2968658593' target=_blank style='color:#2F92EE;'>#舒张功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86585, encryptionId=c2968658593, topicName=舒张功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Wed Apr 10 08:47:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837659, encodeId=5862183e65975, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 31 17:47:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268093, encodeId=77b012680933a, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Mar 17 11:47:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362708, encodeId=541e362e08f1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Mar 15 21:48:14 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
    2019-03-17 hb2008ye
  4. [GetPortalCommentsPageByObjectIdResponse(id=2026161, encodeId=973d202616111, content=<a href='/topic/show?id=c2968658593' target=_blank style='color:#2F92EE;'>#舒张功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86585, encryptionId=c2968658593, topicName=舒张功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Wed Apr 10 08:47:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837659, encodeId=5862183e65975, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 31 17:47:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268093, encodeId=77b012680933a, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Mar 17 11:47:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362708, encodeId=541e362e08f1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Mar 15 21:48:14 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
    2019-03-15 smartxiuxiu

    0

相关资讯

JACC:房颤患者认知功能的降低与亚临床脑损伤相关

房颤患者发生认知功能下降的风险更高,可能是由未知的脑血管损伤引起。本研究的目的旨在评估房颤患者的认知功能和脑血管损伤的相关性。本研究纳入了1737名房颤患者,平均年龄为73 ± 8 岁,女性占28%,90%接受有口服抗凝药物治疗。经过头颅磁共振检查,发现387名(22%)患者有大的非皮质或皮质梗塞(LNCCIs),368名(21%)患者有皮质下小梗死(SNCIs),372名(22%)患者有微出血,

JAHA:血清高密度脂蛋白胆固醇水平与慢性肾脏疾病进展的相关性研究

高密度脂蛋白胆固醇(HDL-C)水平在慢性肾脏疾病(CKD)患者中普遍降低,然而,HDL-C和CKD进展的相关研究甚少。本研究纳入了 KNOW-CKD临床研究中的2168名CKD患者,主要终点事件是肾小球滤过率与基线或终末期肾病相比下降了50%。次要终点事件是终末期肾病的发生。经过平均3.1年时间的随访,335名患者(15.5%)发生了主要终点事件。在多元回归模型分析中,与HDL-C水平在50-5

JAHA:术前肌钙蛋白水平可预测主动脉瓣置换术患者的预后

在接受经导管主动脉瓣置换术的患者中,关于肌钙蛋白对患者预后的预测结果有矛盾的结果,本研究的目的旨在评估经导管主动脉瓣置换术前和术后肌钙蛋白对预后的预测价值。本研究纳入了1390名接受经导管主动脉瓣置换术的患者,平均年龄为83.4±6.8 岁,并对所有患者术前和术后的高敏肌钙蛋白水平进行了检测,主要终点事件是1年的死亡率。患者根据术前的肌钙蛋白水平分成了三组:0.001-0.023μg/L;0.02

Heart:献血与心血管风险

由此可见,该研究结果表明长期、高频率献血对心血管疾病具有保护作用。这种效果仅在女性中观察到,而男性则不然。

JAHA:冠脉搭桥术后社会因素与死亡率的相关性研究

社会因素对冠脉搭桥(CABG)术后死亡率的影响尚不清楚。本研究的目的旨在探讨CABG术后死亡率风险与婚姻状况、收入和教育之间的性别和年龄相关性。本研究纳入了SWEDEHEART数据库中的110742名CABG术后患者(女性占21.3%)。与已婚或同居的患者相比,未婚的女性要比男性的死亡风险更高(HR:1.32, 95% CI 1.20–1.44 vs HR:1.17 ,95% Cl 1.13–1.

盘点:JACC三月第一期研究一览

1.操作时间对血管内血栓切除术预后的影响研究DOI: 10.10